v3.26.1
Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Reporting [Abstract]        
Number of reportable segments | segment 2   2  
Segment Reporting [Line Items]        
Number of reportable segments | segment 2   2  
Net sales $ 6,589 $ 6,022 $ 12,609 $ 11,888
Reclassification to: cost of sales 2,091 2,181 4,301 4,303
Research, development and engineering expenses 434 407 847 812
Selling, general and administrative expenses 2,229 2,079 4,510 4,379
Depreciation and amortization 404 387 799 751
Amortization of intangible assets (175) (187) (355) (354)
Segment operating income 1,659 1,113 2,595 1,950
Goodwill and other impairments (1) (55) (1) (90)
Net earnings 1,276 884 2,021 1,538
MedSurg and Neurotechnology:        
Segment Reporting [Line Items]        
Net sales 3,625 3,305    
Operating Segments        
Segment Reporting [Line Items]        
Net sales 6,589 6,022 12,609 11,888
Reclassification to: cost of sales 2,165 2,031 4,295 3,994
Research, development and engineering expenses 410 381 795 755
Selling, general and administrative expenses 1,795 1,690 3,568 3,437
Depreciation and amortization 192 174 378 344
Amortization of intangible assets (175) (187) (355) (354)
Segment operating income 2,027 1,746 3,573 3,358
Operating Segments | MedSurg and Neurotechnology:        
Segment Reporting [Line Items]        
Net sales 3,625 3,305 6,832 6,361
Reclassification to: cost of sales 1,343 1,264 2,634 2,438
Research, development and engineering expenses 255 228 486 437
Selling, general and administrative expenses 945 909 1,873 1,768
Depreciation and amortization 63 58 120 114
Segment operating income 1,019 846 1,719 1,604
Operating Segments | Orthopaedics        
Segment Reporting [Line Items]        
Net sales 2,964 2,717 5,777 5,527
Reclassification to: cost of sales 822 767 1,661 1,556
Research, development and engineering expenses 155 153 309 318
Selling, general and administrative expenses 850 781 1,695 1,669
Depreciation and amortization 129 116 258 230
Segment operating income 1,008 900 1,854 1,754
Segment Reporting, Reconciling Item, Corporate Nonsegment        
Segment Reporting [Line Items]        
Depreciation and amortization 37 26 66 53
Segment operating income (220) (201) (495) (469)
Segment Reconciling Items        
Segment Reporting [Line Items]        
Amortization of intangible assets (175) (187) (355) (354)
Sale of inventory stepped up to fair value at acquisition 0 (65) 0 (99)
Acquisition and integration-related charges (25) (78) (44) (263)
Structural optimization and other special charges (95) (11) (213) (52)
Goodwill and other impairments (1) (55) (1) (90)
Medical device regulation (5) (7) (10) (19)
Recall-related matters (2) (22) (12) (55)
Regulatory and legal matters (3) (7) (6) (7)
Other Nonoperating Income 158 0 158 0
Net earnings $ 1,659 $ 1,113 $ 2,595 $ 1,950